Objective: The study the levels of liporotein (a) as a nonconventional risk factor in patients with acute myocardial infarction.

Methods: The present study was conducted in the P.G. Dept. of Medicine in the Cardiology Unit, S.N. Medical College, Agra. Patients of any age group willing to take part in the study. Patients who meets the criteria for diagnosing acute myocardial infarction. Determination of Lp(a) levels was done by Immunoturbidimetric test. This test has measuring range from 3-150 mg/dl.

Results: Clinical outcome was judged by mortality at the end of 24 hours, 48 hours and 1 week and a total of 38% of patients succumbed to their illness by the end of the above period. Highest mortality was seen within 24 hours period. Higher LpA values (>20mg/dl)were present in 68.42% of expired patients.63.64% of the patients with mortality within 24 hours had high Lp (a) values while amongst those who died within 48 hours and 1 week, 75% and 75% had high values respectively. There was significant difference in the mean LpA values of patients within 24 hours (T values = 2.183, p value = 0.002) and within 24-48 hours (t values = 1.771, p value = 0.004), 48 hours to 7 days (t value = 1.630, p value = 0.003).

Conclusion: In the search of non-conventional risk factor to explain the present CAD epidemic in north Indian population. Lp(a) is important non-conventional risk factor however other non-conventional risk factors like Apo A1, A2, fibrinogen level are also need to be investigated and explain CAD burden in north Indian population.

Keywords: Lipoprotein (a), acute MI, nonconventional risk factor.

1. Berg K: A new serum type system in men: The Lp system, Acta Pathol microbial scand 1963, 59:369-382.
2. Nguyen TT, Ellefson R, Hodge DO, et al. Predictive value of electrophoretically detected lipoprotein A for coronary heart disease and cerebrovascular disease in a community-based cohort of 9,963 men and women. Circulation 1997;96:1390-7
3. Cobbaert D, Jukena JW, Zwinderman AH, et al. Modulation of lipoprotein A atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol. J Am Coll Cardiol 1997;30:1491-9
4. Schwartzman RA, Cox ID, Poloniecki J, et al. Elevated plasma lipoprotein A is associated with coronary artery diseases in patients with chronic stable angina pectoris. J Am Coll Cardiol1998;31:1260-6.
5. Murai A, Miyahara T, Fujimoto N, et al. Lp(a) lipoprotein is a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986;59:199-204.
6. David J.Moliterno et al. No association between Lp(a) concentrations and presence or absence of coronary Atherosclerosis in African- Americans. Atherosclerosis, Therosclerosis, vascular biopsy 1995, 15:850-855.
7. Bostom AG, Bostom AG, Cupples LA, Jenner JL, Ordovas JM. Seman LJ. Wilson PW, Schaefer EJ, Castelli WP. "Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study". JAMA, 1996; 276: 544 - 548.
8. Sandkamp M, Assman G 1990, "Lipoprotein (a) in PROCAM participants and young myocardial infarction survivors. In: Scanu A ed. Lipoprotein (A). San Diego": Academic Press : 205 - 209.
9. Stubbs P. Seen < Moseley D, O'Connor B, Collinson P, Noble M. 1997 "A prospective study of the role of lipoprotein(a) in the pathogenesis of unstable angina". Eur Heart J, 18: 603-7.
10. WooJ,LamCW."Association of serum lipoprotein(a) concentration with other cardiovascular risk factors in a Chinese population". J. Clin Lab Anal, 5 : 335 - 9.
11. Jurgens G, Taddie Peters W, Koltringer P et al 1995. "Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with the severity and presence of ischemic cerebrovascular disease". Stroke 6: 1841 - 1848.
12. Valentine RJ, Grayburn PA, Vega GL, Grundy SM 1994. "Lp(a) lipoprotein is an independent, discriminating - risk factor for premature peripheral atherosclerosis among white men". Arch Intern Med. 154; 801 -6,
13. Cheng SW, Ting AC, Wong J 1997. "Lipoprotein (a) and its ( 93 )relationship to risk factors and severity of atherosclerotic peripheral vascular disease". Eur J Vase Endovac Surg, 14: 17 - 23.
14. Superko HR, Hecht HS. 2001. "Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification Am. J. Cardiol 88: 260 - 264.
15. Wilcken DE, Wang XL, Greenwood J, Lynch J. 1993 "Lipoprotein(A) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparents". J. Pediatr, 123: 519-26.
16. Durrington PN, Ishola M, Hunt L. Arrol S, Bhatnagar D 1988 "Apolipoproteins (a), Al and B and parental history in men with early onset ischaemic heart disease". Lancet 1: 1070 - 1073.
17. Solymoss BC, Marcil M, Wesolowska E, Gilfix BM, Lesperance J, Campeu L 1993. "Relation of coronary artery disease in women 60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high - density cholesterol ratio". Am J. Cardiol 72: 121 5-121 9.

Dr Kushal Pal

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., 9690795611